Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1

Acute Myeloid Leukemia with t(8;21)(q22;q22.1); RUNX1-RUNX1T1 — Trials · CancerIndex

Clinical trials

Registered studies

166 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: City of Hope Medical Center
Termination share: 29.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (32)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01822015	Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia	completed	Early Phase 1	55	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER	1	Apr 29, 2025	clinicaltrials

Data updated 22 days agoSource updated Apr 29, 2025source: clinicaltrials